- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07293650
PREcision MEDicine In Achalasia (PREMEDIA) (PREMEDIA)
PREcision MEDicina en Acalasia - Un Ensayo Clínico Multicéntrico Aleatorizado de No Inferioridad de POEM Adaptado Corto vs. POEM Estándar para Acalasia No Espástica y Un Estudio de Cohorte Prospectivo Multicéntrico de POEM Adaptado Largo para Trastornos de Motilidad Esofágica Espástica
The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question[s] it aims to answer [is/are]:
- Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms?
- Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut.
Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
The investigators will perform a randomized controlled trial to compare two different approaches to Peroral Endoscopic Myotomy (POEM) for treating achalasia (Types I and II) and esophagogastric junction outflow obstruction (EGJOO). The most widely used treatment for achalasia is POEM but the current approach involves a 9 cm (3.5 inch) myotomy (cutting of the muscle) to open up the tight lower esophageal sphincter to promote food delivery from the esophagus to the stomach. This approach is very effective, with success rates of approximately 90% over the short term. However, the investigators believe that POEM does not require a full 9 cm myotomy and that the investigators can cut much less muscle (approximately 4cm/1.25inches) to achieve similar improvement in symptoms but with less long-term complications. Cutting less muscle may result in less acid reflux, which is the Achilles heel of any successful treatment for achalasia. A shorter muscle cut may also result in less of a complication known as blown-out myotomy, which causes failure of the esophagus to empty its contents and is a major cause of long-term symptom relapse. The investigators have designed this study to determine whether the shorter myotomy (4 cm) is equivalent to the longer myotomy (9 cm) in terms if symptom improvement, but with the possibility of less acid reflux and blown-out myotomy.
Given these questions, the investigators will enroll 370 patients in a randomized trial where patients will receive either the short tailored (4cm/1.25 inches) or the standard myotomy (9cm/3.5 inches). All patients will undergo intraoperative assessment of success of the myotomy by using a special tool called the functional lumen imaging probe (FLIP). The FLIP will measure the opening dimensions of the lower esophageal sphincter and ensure that the myotomy is adequately performed so that the lower esophageal sphincter can open to a level that will improve esophageal emptying/swallowing. The investigators will follow patients for 2 years in a manner similar to how the investigators would follow patients after achalasia treatment in standard clinical practice. The investigators will assess whether symptoms are similar and whether or not there are differences in acid reflux and esophageal emptying. Patients will undergo follow up testing with questionnaires at intervals of 3-6 months over two years and they will have reflux testing (measure acid exposure using a capsule placed during endoscopy) between 6-12 months and a barium esophagram (X ray while drinking barium) at 2 years. The most important aim is to prove that the symptoms and outcomes success/failure) between the two approaches are similar (short myotomy is non-inferior) and the Eckardt score will be the primary questionnaire score for this study. The investigators believe that this study will help define the optimal approach to POEM in achalasia and also help us prevent complications in the future.
Additionally, the investigators will also ask participants to provide a sample of the muscle tissue that is typically cut during the POEM. This tissue will help us develop a tissue bank to help other researchers looking into the causes of why achalasia and these other esophageal diseases occur. The participants can opt out of this part and still continue in the randomized controlled trial.
Tipo de estudio
Inscripción (Estimado)
Fase
- Fase 3
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Elizabeth Yan, BS
- Número de teléfono: 312-908-1723
- Correo electrónico: premedia.dcc@northwestern.edu
Copia de seguridad de contactos de estudio
- Nombre: Yasmin Pina, BS
- Número de teléfono: 312-503-6459
- Correo electrónico: premedia.dcc@northwestern.edu
Ubicaciones de estudio
-
-
Arizona
-
Scottsdale, Arizona, Estados Unidos, 85259
- Aún no reclutando
- Mayo Clinic Arizona
-
-
California
-
La Jolla, California, Estados Unidos, 92037
- Reclutamiento
- University of California San Diego
-
Investigador principal:
- Rena Yadlapati, MD
-
Contacto:
- Alexander Gonsalves, Lead Study Coordinator
- Número de teléfono: 858-246-5236
- Correo electrónico: PREMEDIA@health.ucsd.edu
-
-
Colorado
-
Denver, Colorado, Estados Unidos, 80217
- Aún no reclutando
- University of Colorado Denver
-
-
Florida
-
Gainesville, Florida, Estados Unidos, 32611
- Reclutamiento
- University of Florida
-
Investigador principal:
- Peter Draganov, MD
-
Contacto:
- April Goddard, Lead Study Coordinator, PA-C
- Número de teléfono: 352-273-9483
- Correo electrónico: DOM-GIResereachTeam@ad.ufl.edu
-
Orlando, Florida, Estados Unidos, 32803
- Aún no reclutando
- Adventist Health System/Sunbelt, Inc
-
-
Georgia
-
Atlanta, Georgia, Estados Unidos, 30322
- Reclutamiento
- Emory University
-
Investigador principal:
- Anand Jain, MD
-
Contacto:
- Halley Fowler, Lead Study Coordinator
- Número de teléfono: 404-778-3184
- Correo electrónico: halley.fowler@emory.edu
-
-
Illinois
-
Chicago, Illinois, Estados Unidos, 60611
- Reclutamiento
- Northwestern University
-
Investigador principal:
- John Pandolfino, MD
-
Contacto:
- Eric Pfannkuche, Lead Study Coordinator
- Número de teléfono: 312-926-4525
- Correo electrónico: PREMEDIA@northwestern.edu
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21218
- Aún no reclutando
- Johns Hopkins University
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02114
- Reclutamiento
- Massachusetts General Hospital
-
Contacto:
- Madison Paylor, Lead Study Coordinator
- Número de teléfono: 617-726-0196
- Correo electrónico: premedia@mgb.org
-
Investigador principal:
- Kyle Staller, MD
-
-
Missouri
-
St Louis, Missouri, Estados Unidos, 63110
- Reclutamiento
- Washington University
-
Contacto:
- Darren Nix, Lead Study Coordinator
- Número de teléfono: 314-273-1432
- Correo electrónico: Premediasurgerytrial@wustl.edu
-
Investigador principal:
- Chandra Gyawali, MD
-
-
New York
-
New York, New York, Estados Unidos, 10065
- Aún no reclutando
- Weill Cornell Medical College
-
-
North Carolina
-
Charlotte, North Carolina, Estados Unidos, 28204
- Reclutamiento
- Atrium Health/Wake Forest
-
Investigador principal:
- Badih Elmunzer, MD
-
Contacto:
- Greg Scarola, Lead Study Coordinator
- Número de teléfono: (704) 355-2000
- Correo electrónico: PREMEDIA@advocatehealth.org
-
-
Ohio
-
Cleveland, Ohio, Estados Unidos, 44109
- Reclutamiento
- MetroHealth Medical Center
-
Investigador principal:
- Ronnie Fass, MD
-
Contacto:
- Stephanie Baker, Lead Study Coordinator
- Número de teléfono: 216-778-5736
- Correo electrónico: premedia@metrohealth.org
-
Cleveland, Ohio, Estados Unidos, 44106
- Aún no reclutando
- Case Western Reserve University
-
-
Tennessee
-
Nashville, Tennessee, Estados Unidos, 37232
- Reclutamiento
- Vanderbilt University Medical Center
-
Investigador principal:
- Dhyanesh Patel, MD
-
Contacto:
- Larry Raber, Lead Study Coordinator
- Número de teléfono: 615-322-4643
- Correo electrónico: larry.w.raber@vumc.org
-
-
Texas
-
Dallas, Texas, Estados Unidos, 75246
- Reclutamiento
- Baylor Scott & White Health
-
Contacto:
- Neomy Flores, Lead Study Coordinator
- Número de teléfono: 214-820-9704
- Correo electrónico: premedia@bswhealth.org
-
Investigador principal:
- Vani Albertson Konda, MD
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria
- Age ≥ 18
- Type I achalasia or type II achalasia or cEGJOO
- Eckardt score > 3
Exclusion Criteria
The following exclusion criteria are for the RCT, but 1-13 below also pertain to the observational study:
- Prior POEM
- Prior surgical treatment for achalasia
- Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
- Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
- Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
- Known secondary achalasia related to malignancy (pseudoachalasia)
- Known eosinophilic esophagitis
- Diverticulum (> 2 cm) in distal esophagus
- Megaesophagus
- Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
- Pregnancy
- Standard contraindications to general anesthesia
- Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
- Unwillingness or inability to consent for the study
- Anticipated inability to follow protocol
- Weekly (or more frequent) opioid medication use in the last 2 years
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Cuadruplicar
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Miotomía Estándar
|
Myotomy during POEM of 8-10 cm in length, extending 2-3 cm into the gastric cardia; intention to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
|
Experimental: Miotomía Corta Personalizada
|
Myotomy during POEM of 4-5 cm in length, extending 1-2 cm into the gastric cardia; intend to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Clinical Response-Overall
Periodo de tiempo: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Sex
Periodo de tiempo: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Race
Periodo de tiempo: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
|
Clinical Response-by Ethnicity
Periodo de tiempo: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- PREMEDIA (Pro00083748) - 01
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- SAVIA
- RSC
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .